Dr Bruce Levine of the University of Pennsylvania will receive the Genome Valley Excellence Award 2026 at BioAsia for his groundbreaking work in cell...

DelveInsight’s “CAR T-Cell Therapy Pipeline Insight 2025” report provides comprehensive insights about 180+ companies and 200+...

DelveInsight’s “CAR T-Cell Therapy Pipeline Insight 2025” report provides comprehensive insights about 180+ companies and 200+...

Leading Australian blood cancer researchers have delivered a breakthrough treatment that significantly improves survival and quality of life for young...

Leading Australian blood cancer researchers have delivered a breakthrough treatment that significantly improves survival and quality of life for young...

Eli Lilly is set to buy Orna Therapeutics for $2.4B to expand in vivo CAR-T and circular RNA capabilities, signaling a long-term push to diversify its...

Cell and gene therapies, or CGT, have come a long way since they were first introduced. In the last few decades, both cell therapy -- the...

Researchers at NREL found that UV exposure can cause significant, partly non-recoverable degradation in TOPCon solar cells, with strong cell-to-cell...

West Australian and Victorian cancer researchers have found a way to turbocharge cancer-fighting cells to further improve a life-saving immunotherapy.

Key Highlights Motixafortide effectively mobilized sufficient hematopoietic stem cells (HSCs) in patients with sickle cell disease and...